Clinical Trials Logo

Covid19 clinical trials

View clinical trials related to Covid19.

Filter by:

NCT ID: NCT05481203 Completed - Anxiety Clinical Trials

The Effect Of Distraction Methods On Fear And Anxiety In Children Before The Covid 19 Test

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Aim: This research will be carried out to determine the effect of distracting methods on fear and anxiety in children before the COVID test.

NCT ID: NCT05481190 Completed - Quality of Life Clinical Trials

The Impact Of A Tele-Exercise Program For Children With Cystic Fibrosis During The Covid-19 Pandemic On Quality Of Life

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The aim of this study was to examine the effect of the tele-exercise program applied to children with cystic fibrosis in the Covid-19 pandemic on the quality of life and the symptoms experienced during exercise

NCT ID: NCT05480436 Recruiting - COVID-19 Clinical Trials

Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis Population

Start date: August 5, 2022
Phase: Phase 4
Study type: Interventional

Evaluation of immunogenicity and safety of inactivated COVID-19 vaccine (BBIBP-Corv) coadministered with PPV23 and IIV4 in hemodialysis population.

NCT ID: NCT05479383 Active, not recruiting - COVID-19 Clinical Trials

Tobacco Use and Uptake of COVID-19 Vaccinations

Start date: October 2, 2017
Phase:
Study type: Observational

This is an observational study of participants in two general population health surveys (FinSote 2018 and 2020) who are followed up for their COVID-19 vaccinations or end of follow-up. The primary objective is to examine the association between tobacco use and COVID-19 vaccine uptake and between-dose spacing.

NCT ID: NCT05477394 Completed - COVID-19 Clinical Trials

Metabolic Syndrome as Prognostic Factor for Outcome of Sever SARS-COV-2 Cases.

COVID19
Start date: April 1, 2021
Phase:
Study type: Observational

SARS-COV-2 crisis is a severe public health concern in the world. It is now well recognized that older age, diabetes mellitus, obesity (BMI > 30 kg/m2), and hypertension increase the risk of complications and death in SARS-COV-2 patients. This study will describe the spectrum of clinical features, the likely pathophysiologic mechanisms, and potential implications for the management of metabolic syndrome in SARS-COV-2 patients.

NCT ID: NCT05477199 Completed - Clinical trials for Post-COVID-19 Syndrome

Physiotherapy in Post COVID-19 Syndrome Patients

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

Patients who have undergone COVID-19 infection often have long-term sequelae. One of the most prevalent sequelae is pain. The main objective of this research is to investigate the efficacy of a cognitive behavioral principles-based treatment program in fear avoidance beliefs, disability, pain catastrophizing and pain interference.

NCT ID: NCT05477186 Completed - COVID-19 Clinical Trials

Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old

Start date: August 12, 2022
Phase: Phase 1
Study type: Interventional

Prevention of COVID-19 caused by SARS-CoV-2.

NCT ID: NCT05476848 Completed - COVID-19 Clinical Trials

Relationship Between Oral Findings and Salivary Factors in Sars-Cov-2 Patients

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Two hundred individuals will be formed according to the study and control groups: Group-1: coronavirus 2 (Covid-19) (+) patients (n=100) and Group-2: Healthy individuals (in which the volunteers will be included due to group-1) (n=100). Oral examinations including DMFT scores, salivary flow rate, visible gingival index scores and radiographs (OPG) will be performed on both groups on the 1st appointment. Oral swap samples will be collected with sterile swap brushes (Six sample for each person) on the 1st, 7th and 30th days to evaluate the salivary immunoglobulins (Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM)) and cytokine (IL-1, IL-6, IL-10) levels. Blood samples will be collected to validate the oral swap test results.

NCT ID: NCT05476835 Completed - Clinical trials for Post COVID-19 Condition

Effect of Pulmonary Rehabilitation Program on Post Hospitalization Severe COVID- 19 Patients

Start date: May 15, 2021
Phase: N/A
Study type: Interventional

COVID-19 infection was discovered to be the major global cause of a serious respiratory illness toward the end of 2019. The majority of COVID-19 patients experience mild disease, while about 14% go on to have severe disease and 6% end up in critical condition. An evidence-based standard of therapy called pulmonary rehabilitation includes exercise training, education, and behavior modification to help people with lung illness feel better physically and mentally. The aim of the study to evaluate the effect of pulmonary rehabilitation program on severe post covid19 patients (post hospitalization) regarding pulmonary function tests and dyspnea score.

NCT ID: NCT05476822 Withdrawn - Clinical trials for Spike Protein IgG Antibody

Profiling Spike Protein Antibody Response Post COVID-19 Booster

Start date: August 2022
Phase:
Study type: Observational

A descriptive study that will quantify the mean IgG antibodies remaining in vaccinated healthy participants after their COVID booster.